Efficacy of Narrow-band UVB Combined with Transfer Factor Capsules and Halometasone Cream in Treatment of Vitiligo
Jinhua Liu
Abstract
Jinhua Liu
Abstract
Objective To investigate the clinical efficacy of the narrow-band ultraviolet B (NB-UVB) radiation combined with transfer factor capsules and halometasone cream in treatment of vitiligo. Methods 72 patients with vitiligo were divided into two groups randomly. The treatment group (35cases) was treated with transfer factor capsules and topical 0.05% betamethasone cream combined with NB-UVB radiation, as the control group (37cases) only given transfer factor capsules and topical 0.05% betamethasone cream. The therapeutic effect and safety were evaluated the same time after the treatment. Results The total response rate (77.14%) in the treatment group was much higher than that (43.24%) of the control group. It showed significant difference between the two groups (P0.05). Conclusion The clinical data demonstrate that the treatment of narrow-band ultraviolet B (NB-UVB) radiation combined with transfer factor capsules and halometasone cream, which is more effective and safety for vitiligo.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy of the narrow-band ultraviolet B (NB-UVB) radiation combined with transfer factor capsules and halometasone cream in treatment of vitiligo. Methods 72 patients with vitiligo were divided into two groups randomly. The treatment group (35cases) was treated with transfer factor capsules and topical 0.05% betamethasone cream combined with NB-UVB radiation, as the control group (37cases) only given transfer factor capsules and topical 0.05% betamethasone cream. The therapeutic effect and safety were evaluated the same time after the treatment. Results The total response rate (77.14%) in the treatment group was much higher than that (43.24%) of the control group. It showed significant difference between the two groups (P0.05). Conclusion The clinical data demonstrate that the treatment of narrow-band ultraviolet B (NB-UVB) radiation combined with transfer factor capsules and halometasone cream, which is more effective and safety for vitiligo.
Key concepts: Vitiligo, Medicine, Dermatology, Betamethasone, Ultraviolet b, Clinical efficacy, Significant difference, Surgery